Patents by Inventor James Donald Shull

James Donald Shull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10934590
    Abstract: Described herein is the use of Agouti Signaling Protein (ASIP), in addition to certain other melanocortin signaling network (MSN) genes, as prognostic and predictive biomarkers for the progression of breast cancer. In particular, the novel biomarkers can be used to determine if a female breast cancer patient is at risk of progressing to metastatic disease and thus also be used to direct treatment of the patient.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: March 2, 2021
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventor: James Donald Shull
  • Publication number: 20170342502
    Abstract: Described herein is the use of Agouti Signaling Protein (ASIP), in addition to certain other melanocortin signaling network (MSN) genes, as prognostic and predictive biomarkers for the progression of breast cancer. In particular, the novel biomarkers can be used to determine if a female breast cancer patient is at risk of progressing to metastatic disease and thus also be used to direct treatment of the patient.
    Type: Application
    Filed: May 18, 2017
    Publication date: November 30, 2017
    Inventor: James Donald Shull